VTEU: Phase II Clinical Trial to Evaluate Influenza Vaccines

NIH RePORTER · NIH · N01 · $5,000 · view on reporter.nih.gov ↗

Abstract

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations.

Key facts

NIH application ID: 10710496
Project number: 272201300021I-P00004-27200020-1
Recipient: SAINT LOUIS UNIVERSITY
Principal Investigator: DANIEL HOFT
Activity code: N01
Funding institute: NIH
Fiscal year: 2022
Award amount: $5,000
Award type: —
Project period: 2017-07-28 → 2023-04-30